Pessin Award Lecture 2008: Lessons from the Stroke PROTECT program

Journal of the Neurological Sciences

Volumn 275, Issue 1-2, 2008, Pages 1-6

  Ovbiagele, Bruce ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ischemic; Outcomes; Practice; Prevention; Risk factors; Stroke

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT;

CEREBROVASCULAR ACCIDENT; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HUMAN; LIFESTYLE MODIFICATION; MEDICAL EDUCATION; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; STROKE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK;

EVIDENCE-BASED MEDICINE; HUMANS; PATIENT DISCHARGE; RECURRENCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; STROKE;

EID: 55749107445     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.07.014     Document Type: Review

References (44)

1. NINDS rt-PA Stroke Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Gorelick P. Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal. Neuroepidemiology 16 (1997) 163-173
3. Sacco R.L., Adams R., Albers G., Alberts M.J., Benavente O., Furie K., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
4. Holloway R., Benesch C., and Rush S.R. Stroke prevention: narrowing the evidence-practice gap. Neurology 54 (2000) 1899-1906
5. Reeves M.J., Arora S., Broderick J.P., Frankel M., Heinrich J.P., Hickenbottom S., et al. Acute stroke care in the us: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36 (2005) 1232-1240
6. Ovbiagele B., and Saver J.L. Ensuring management of vascular risk factors after stroke. Rev Neurol Dis 3 (2006) 93-100
7. Ovbiagele B., Saver J.L., Bang H., Chambless L.E., Nassief A., et al. Statin treatment and adherence to national cholesterol guidelines after ischemic stroke. Neurology 66 (2006) 1164-1170
8. Pearson T.A., Laurora I., Chu H., and Kafonek S. The lipid treatment assessment project (l-tap): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 160 (2000) 459-467
9. University Health System Consortium Ischemic Stroke Clinical Benchmarking Project Clinical Database Analysis-2001: University Health System Consortium Ischemic Stroke Database Report #3, 2002
10. Ovbiagele B., Saver J.L., Fredieu A., Suzuki S., McNair N., Dandekar A., et al. Protect: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 63 (2004) 1217-1222
11. LaBresh K.A., Reeves M.J., Frankel M.R., Albright D., and Schwamm L.H. Hospital treatment of patients with ischemic stroke or transient ischemic attack using the "Get with the guidelines" Program. Arch Intern Med 168 (2008) 411-417
12. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 4 (2006) e25-e146
13. Coull A., Lovett J.K., and Rothwell P.M. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. Bmj (2004) 328:326
14. Hankey G. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 16 Suppl 1 (2003) 14-19
15. Hardie K., Hankey G.J., Jamrozik K., Broadhurst R.J., and Anderson C. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke 34 (2003) 1842-1846
16. Coutts S.B., Hill M.D., Simon J.E., Sohn C.H., Scott J.N., and Demchuk A.M. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 65 (2005) 513-517
17. Leary M.C., and Saver J.L. Annual incidence of first silent stroke in the united states: a preliminary estimate. Cerebrovasc Dis 16 (2003) 280-285
18. Sacco R., Wolf P.A., and Gorelick P.B. Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology 53 (1999) S15-24
19. Straus S.E., Majumdar S.R., and McAlister F.A. New evidence for stroke prevention: scientific review. Jama 288 (2002) 1388-1395
20. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H., McGovern P.G., Howard G., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30 (1999) 736-743
21. Fonarow G. Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis. Vasc Med 7 (2002) 187-194
22. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Peth S., Kopp H., et al. manifestations of atherosclerosis in various vascular regions. Similarities and differences regarding epidemiology, etiology and prognosis. Med Klin 97 (2002) 221-228
23. Rauch U., Osende J.I., Fuster V., Badimon J.J., Fayad Z., and Chesebro J.H. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med 134 (2001) 224-238
24. Caplan L. Prevention of strokes and recurrent strokes. J Neurol Neurosurg Psychiatry 64 (1998) 716
25. Albers G., Amarenco P., Easton J.D., Sacco R.L., and Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 483S-512S
26. Reeves M.J., Arora S., Broderick J.P., Frankel M., Heinrich J.P., Hickenbottom S., et al. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry. Stroke 36 (2005) 1232-1240
27. Qureshi A.I., Suri M.F., Guterman L.R., and Hopkins L.N. Ineffective secondary prevention in survivors of cardiovascular events in the us population: report from the Third National Health and Nutrition Examination Survey. Arch Intern Med 161 (2001) 1621-1628
28. Ovbiagele B., Hills N.K., Saver J.L., and Johnston S.C. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event. Stroke 36 (2005) 1944-1947
29. Mullard A.J., Reeves M.J., Jacobs B.S., Kothari R.U., Birbeck G.L., Maddox K., et al. Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry. Stroke 37 (2006) 44-49
30. Isles C., Campbell N., and Stuckey N. Secondary prevention of CHD and the national service framework: barriers to implementation. Cardiabetes 1 (2001) 11-17
31. Fonarow G., Gawlinski A., Moughrabi S., and Tillisch J.H. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). Am J Cardiol 87 (2001) 819-822
32. Aronow H., Novaro G.M., Lauer M.S., Brennan D.M., Lincoff A.M., Topol E.J., et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med 163 (2003) 2576-2582
33. Muhlestein J., Horne B.D., Bair T.L., Li Q., Madsen T.E., Pearson R.R., and Anderson J.L. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 87 (2001) 257-261
34. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 106 (2002) 1893-1900
35. Ovbiagele B., Saver J.L., Fredieu A., Suzuki S., Selco S., Rajajee V., et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 35 (2004) 2879-2883
36. Kapadia M., Berlow E., Campbell-Voytal K., Madhavan M., Rajamani K., Janisse J., et al. Can the UCLA StrokePROTECT program be applied to an urban population. Presented at the International Stroke Conference in New Orleans, Louisiana (February 2008)
37. Ovbiagele B., Kidwell C.S., Selco S., Razinia T., and Saver J.L. Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program. Cerebrovasc Dis 20 (2005) 280-282
38. Rahiman A., Saver J.L., Porter V., Buxton W., McNair N., Razinia T., et al. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis 17 (2008) 5-8
39. Zurru M.C., Alonzo C., Brescacin L., Romano M., Rojas J., Guajardo M.E., et al. Presentación del programa protege-acv características generales del programa experiencia del primer año. Presented at Conferencia Internacional de Stroke. Buenos Aires, Argentina (September 14, 2007)
40. Thomas M. Local opinion leaders to improve health professional practice and healthcare outcomes (Cochrane Review). The Cochrane Library (1997)
41. Soumerai S.B., and Avorn J. Principles of educational outreach ('academic detailing') to improve clinical decision making. Jama 263 (1990) 549-556
42. Balas E.A., Austin S.M., Mitchell J.A., Ewigman B.G., Bopp K.D., and Brown G.D. The clinical value of computerized information services. A review of 98 randomized clinical trials. Arch Fam Med 5 (1996) 271-278
43. Grilli R. Media have key role in shaping use of health services. Bmj 319 (1999) 786-787
44. O'Brien T. Audit and feedback versus alternative strategies: effects on professional practice and healthcare outcomes (Cochrane Review). The Cochrane Library - Issue 4 (1999)